Steven Cohen’s ResMed RMD Stock Holding History

Steven Cohen’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-800	Closed	-$219K	–	4123
2025 Q3	$219K	Hold	800	–	–	﹤0.01%	2117
2025 Q2	$206K	Buy	+800	New	+$191K	﹤0.01%	1979
2025 Q1	–	Sell	-50,000	Closed	-$11.4M	–	2462
2024 Q4	$11.4M	Buy	+50,000	New	+$12M	0.03%	644

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Steven Cohen's RMD Position: Q3 2023 in Review

Steven Cohen sold out of ResMed (RMD) in Q3 2023, closing a stake of 605,243 shares — an estimated $132M sold.

Steven Cohen first reported a position in RMD in Q4 2014 and held it in 16 quarters. The position peaked at $132M in Q2 2023. 658 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

Steven Cohen reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
Steven Cohen sold 605,243 ResMed shares in Q3 2023, an estimated $132M.
Steven Cohen first reported a position in ResMed in Q4 2014 and held it in 16 quarters.
Steven Cohen's ResMed position peaked at $132M in Q2 2023.
658 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.